| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 130.19B | 125.11B | 111.43B | 123.84B | 115.34B | 69.13B |
| Gross Profit | 14.53B | 15.42B | 13.02B | 13.24B | 15.55B | 9.50B |
| EBITDA | 11.14B | 12.16B | 9.98B | 10.52B | 13.33B | 7.46B |
| Net Income | 6.93B | 5.21B | 3.82B | 5.32B | 4.31B | 175.00M |
Balance Sheet | ||||||
| Total Assets | 98.82B | 86.97B | 77.14B | 75.45B | 71.10B | 66.14B |
| Cash, Cash Equivalents and Short-Term Investments | 2.42B | 3.70B | 981.00M | 1.03B | 679.00M | 1.74B |
| Total Debt | 19.47B | 8.50B | 7.94B | 9.23B | 8.44B | 12.30B |
| Total Liabilities | 37.90B | 27.93B | 23.53B | 26.30B | 27.20B | 25.73B |
| Stockholders Equity | 52.91B | 52.27B | 47.44B | 43.39B | 38.52B | 35.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.02B | 1.02B | 905.00M | 4.19B | -9.58B |
| Operating Cash Flow | 0.00 | 5.31B | 3.70B | 3.24B | 6.28B | -5.40B |
| Investing Cash Flow | 0.00 | -2.32B | -2.68B | -2.54B | -2.63B | -7.37B |
| Financing Cash Flow | 0.00 | -279.00M | -1.07B | -553.00M | -4.71B | 10.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.27B | 8.89 | ― | 4.93% | 3.19% | 1.83% | |
78 Outperform | ¥10.87B | 7.66 | ― | 3.48% | 0.24% | 20.23% | |
71 Outperform | ¥36.52B | -5.59 | ― | 2.25% | 12.79% | -15.37% | |
69 Neutral | ¥6.67B | -102.51 | ― | 1.06% | 6.41% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥21.78B | 3.53 | ― | 4.33% | 5.12% | ― | |
45 Neutral | ¥7.98B | -73.23 | ― | ― | -19.32% | -171.53% |